Pulsed Radiofrequency Versus Hyaluronidase Hydrodissection for Treatment of Carpal Tunnel Syndrome

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-80
SponsorSohag University

About this trial

The aim of this study is to compare the clinical efficacy and safety of ultrasound-guided pulsed radiofrequency and hyaluronidase hydrodissection in the treatment of carpal tunnel syndrome. This research seeks to evaluate both techniques in terms of pain relief, functional improvement, nerve conduction parameters, and potential complications, in order to identify the more effective minimally invasive approach for managing carpal tunnel syndrome.

Eligibility criteria

Qualifiers

Adults aged 20-80 years

Clinical diagnosis of CTS with symptoms for at least 3 months

Electrophysiological evidence of mild to moderate CTS

No previous intervention for CTS in the affected hand

Disqualifiers

Previous wrist surgery or trauma

Medical history of polyneuropathy, thoracic outlet syndrome, or brachial plexopathy

Coagulopathy or local infection at injection site

Pregnancy or breastfeeding

Trial design

Treatments tested in this trial

  • Pulsed Radiofrequency
  • Hyaluronidase Hydrodissection

Treatment groups

56 Participants
are divided into 2 treatment groups

Sponsors and collaborators